Abstract
The objective of this study was to evaluate the potential role of newly developed, advanced magnetic resonance (MR) imaging techniques (spectroscopy, diffusion and perfusion imaging) in diagnosing brain gliomas, with special reference to histological typing and grading, treatment planning and posttreatment follow-up. Conventional MR imaging enables the detection and localisation of neoplastic lesions, as well as providing, in typical cases, some indication about their nature. However, it has limited sensitivity and specificity in evaluating histological type and grade, delineating margins and differentiating oedema, tumour and treatment side-effects. These limitations can be overcome by supplementing the morphological data obtained with conventional MR imaging with the metabolic, structural and perfusional information provided by new MR techniques that are increasingly becoming an integral part of routine MR studies. Incorporation of such new MR techniques can lead to more comprehensive and precise diagnoses that can better assist surgeons in determining prognosis and planning treatment strategies. In addition, the recent development of new, more effective, treatments for cerebral glioma strongly relies on morphofunctional MR imaging with its ability to provide a biological interpretation of these characteristically heterogeneous tumours.
Riassunto
Lo scopo del lavoro è di illustrare le potenzialità delle nuove e più avanzate modalità di studio RM (spettroscopia, diffusione, perfusione) nella diagnostica dei gliomi cerebrali, con particolare riferimento alla definizione dell’istotipo e del grading, alla pianificazione del trattamento e al follow-up post-trattamento. Con la RM di base è possibile nei casi tipici identificare la lesione neoplastica, stabilirne la sede e la topografia e proporre un’ipotesi di natura. Vi è però una limitata sensibilità e specificità nella definizione dell’istotipo e del grading, nell’individuazione dei margini neoplastici e nella differenziazione tra tumore ed edema o effetti del trattamento. È necessario pertanto integrare le informazioni fornite dalla RM di base con le informazioni di carattere metabolico, strutturale ed emodinamico fornite dalle più recenti tecniche RM, oramai parte integrante di uno studio di routine. In tal modo sono possibili diagnosi sempre più precise ed esaustive per il chirurgo, necessarie per definire la prognosi e l’impostazione delle diverse strategie terapeutiche. Inoltre, il recente sviluppo di nuovi e più efficaci trattamenti ha reso sempre più necessario uno studio RM morfofunzionale con cui ottenere in maniera non invasiva una “neuropatologia in vivo” e quindi un’interpretazione biologica della eterogeneità tipica di tali tumori.
Similar content being viewed by others
References/Bibliografia
Ohgaki H, Kleihues P (2005) Epidemiology and etiology of glioma. Acta Neuropatholo 109:193–108
Rampling R, James A, Papanastassiou V (2004) The present and future management of malignant brain tumours: surgery, radiotherapy, chemotherapy. J Neurol Neurosurg Psych 75:24–30
Jackson RJ, Fuller GN, Abi-Said D et al (2001) Limitations of stereotactic biopsy in the initial management of gliomas. Neuro-oncol 3:193–200
Nelson SJ (2003) Multivoxel magnetic resonance spectroscopy of brain tumors. Mol Cancer Ther 2:497–507
Law M, Yang S, Wang H et al (2003) Glioma grading: sensitivity, specificity, and predictive value of perfusion MR imaging and proton MR spectroscopic imaging compared with conventional MR imaging. AJNR Am J Neuroradiol 24:1989–1998
Rabinov JD, Lee PL, Barker FG et al (2002) In vivo 3-T MR spectroscopy in the distinction of recurrent glioma versus radiation effects: initial experience. Radiology 225:871–879
Li X, Lu Y, Pirzkall A, et al (2002) Analysis of the spatial characteristics of metabolic abnormalities in newly diagnosed glioma patients. J Magn Reson Imag 16:229–237
Howe FA, Barton SJ, Cudlip SA et al (2003) Metabolic profiles of human brain tumors using quantitative in vivo 1H magnetic resonance spectroscopy. Magn Reson Med 49:223–232
Howe FA, Opstad KS (2003) 1H MR spectroscopy of brain tumours and masses. NMR Biomed 16:123–131
Möller-Hartmann W, Herminghaus S, Krings T et al (2002) Clinical application of proton magnetic resonance spectroscopy in the diagnosis of intracranial mass lesions. Neuroradiology 44:371–381
Rees J (2003) Advances in magnetic resonance imaging of brain tumours. Curr Opin Neurol 16:643–650
Kim JH, Chang KN, Na DG et al (2006) 3 T 1H-MRS spectroscopy in grading of cerebral gliomas: comparison of short and intermediate scho time sequences. AJNR Am J Neuroradiol 27:1412–1418
Nelson SJ, Graves E, Pirzkall A et al (2002) In vivo molecular imaging for planning radiation therapy of gliomas: an application of 1H MRSI. J Magn Reson Imag 16:464–476
Dowling C, Bollen AW, Noworolski SM et al (2001) Preoperative proton MR spectroscopic imaging of brain tumors: correlation with histopathologic analysis of resection specimens. AJNR Am J Neuroradiol 22:604–612
Graves EE, Nelson SJ, Vigneron DB et al (2000) A preliminary study of the prognostic value of proton magnetic resonance spectroscpic imaging in gamma knife radiosurgery of recurrent malignant glioma. Neurosurg 46:319–326
Graves EE, Nelson SJ, Vigneron DB et al (2001) Serial proton MR spectroscopic imaging of recurrent malignat gliomas after gamma knife radiosurgery. AJNR Am J Neuroradiol 22:613–624
Tedeschi G, Lundbom N, Raman R et al (1997) Increased choline signal coinciding with malignant degeneration of cerebral gliomas: a serial proton magnetic resonance spectroscopy imaging study. J Neurosurg 87:516–524
Lichy MP, Bachert P, Hamprecht F et al (2006) Application of 1H-MRS spectroscopic imaging in radiation oncology: choline a marker for determining the relatove probability of tumor progression after radiation of glial brain tumors. Rofo 178:627–633
Murphy PS, Rowland IJ, Viviers L et al (2003) Could assessment of glioma methylene lipid resonance by in vivo 1H-MRS be of clinical value? Br J Radiol 76:459–463
Pirzkall A, Mcknight TR, Graves EE et al (2001) MR-spectroscopy guided target delineation for high-grade gliomas. Int J Radiat Oncol Biol Phys 50:915–928
Weybright P, Sundgren PC, Maly P et al (2005) Differentiation between brain tumor recurrence and radiation injury using MR spectroscopy. AJR Am J Roentgenol 185:1471–1476
Zeng QS, Li CF, Zhang K et al (2007) Multivoxel 3D proton MR spectroscopy in the distinction of recurrent glioma from radiation injury. J Neurooncol 84:63–69
Rock JP, Scarpace L, Hearshen D et al (2004) Associations among magnetic resonance spectroscy, apparent diffusion coefficients, and imageguided histopatology with special attention to radiotion necrosis. Neurosurg 54:1111–1117
Balmaceda C, Critchell D, Mao X et al (2006) Multisection 1H magnetic resonance spectroscopic imaging assessment of glioma response to chemiotherapy. J Neurooncol 76:185–191
Kono K, Inoue Y, Nakayama K et al (2001) The role of diffusion-weighted imaging in patients with brain tumors. AJNR Am J Neuroradiol 22:1081–1088
Stadnik TW, Chaslis C, Michotte A et al (2001) Diffusion-weighted MR imaging of intracerebral masses: comparison with conventional MR imaging and histologic findings. AJNR Am J Neuroradiol 22:969–976
Rollin N, Guyota J, Streichenberger N et al (2006) Clinical relevance of diffusion and perfusion magnetic resonance imaging in assessing intraaxial brain tumors. Neuroradiology 48:150–159
Lam WWM, Poon WS, Metreweli C (2002) Diffusion MR imaging in glioma: does it have any role in the preoperation determination of grading of glioma? Clinical Radiology 57:219–225
Brunberg JA, Chenevert TL, McKeever PE et al (2005) In vivo MR determination of water diffusion coefficients and diffusion anisotropy: correlation with structural alteration in gliomas of the cerebral hemisferes. AJNR Am J Neuroradiol 16:361–371
van Westen D, Litt J, Englund E et al (2006) Tumor extension in high-grade gliomas assessed with diffusion magnetic resonance imaging: value and lesion-to-brain ratios of apparent diffusion coefficient and fractional anisotropy. Acta Radiol 47:311–319
Lu S, Ahn D, Johnson G et al (2003) Peritumoral diffusion tensor imaging of high grade gliomas and metastatic brain tumours. AJNR Am J Neuroradiol 24:937–941
Romano A, Ferrante M, Cipriani V et al (2007) Role of magnetic resonance tractography in the preoperative planning and intraoperative assessment of patients with intra-axial brain tumors. Radiol Med 112:906–920
Smith JS, Cha S, Mayo MC et al (2005) Serial diffusion-weighted magnetic resonance imaging in cases of glioma: distinguishing tumor recurrence from postresection injury. J Neurosurg 103:428–438
Hein PA, Eskey CJ, Dunn JF et al (2004) Diffusion-weighted imaging in the follow up of treated high grade gliomas: tumor recurrence versus radiation injury. AJNR Am J Neuroradiol 25:201–209
Sudgren PC, Fan X, Weibright P et al (2006) Differentiation of recurrent brain tumor versus radiation injury using diffusion tensor imaging in patients with new contrast-enhancing lesions. Magn Reson Imaging 24:1131–1142
Cha S (2006) Update on brain tumor imaging: from anatomy to physiology. AJNR Am J Neuroradiol 27:475–487
Covarrubias DJ, Rosen BR, Lev MH (2004) Dynamic magnetic resonance perfusion imaging of brain tumors. Oncologist 9:528–537
Barbier E, Lamalle L, Decorps M (2001) Methodology of brain perfusion imaging. J Magn Reson Imag 13:496–520
Hakyemez B, Erdogan C, Bolca N et al (2006) Evaluation of different cerebral mass lesions by perfusion-weighted MR imaging. J Magn Reson Imag 24:817–824
Leon SP, Folkerth RD, Black PM (1996) Microvessel density is a prognostic indicator for patients with astroglial brain tumors. Cancer 77:362–372
Spampinato MV, Smith JK, Kwock L et al (2007) Cerebral blood volume measurements and proton MR spectroscopy in grading of oligodendroglial tumors. AJR Am J Roentgenol 188:204–212
Law M, Yang S, Babb JS et al (2004) Comparison of cerebral blood volume and vascular permeability from dynamic susceptibility contrast-enhanced perfusion MR imaging with glioma grade. AJNR Am J Neuroradiol 25:746–755
Chaskis C, Stadnik T, Michotte A et al (2006) Prognostic value of perfusion-weighted imaging in brain glioma: a prospective study. Acta Neurichir 148:277–285
Lev MH, Ozsunar Y, Henson JW et al (2004) Glial tumor grading and outcome prediction using dynamic spin-echo MR susceptibility mapping compared with conventional contrast-enhanced MR: confounding effect of elevated rCBV of oligondendrogliomas. AJNR Am J Neuroradiol 25:214–221
Di Costanzo A, Pollice S, Trojsi F et al (2008) Role of perfusion-weighted imaging at 3 Tesla in the assessment of malignancy of cerebral gliomas. Radiol Med 113:134–143
Law M, Cha S, Knopp EA et al (2002) High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging. Radiology 222:715–721
Bulakbasi N, Kocaoglu M, Ors F et al (2003) Combination of single-voxel proton spectroscopy and apparent diffusion coefficient calculation in the evaluation of common brain tumours. AJNR Am J Neuroradiol 23:225–233
Oshiro S, Tsugu H, Komatsu F et al (2007) Quantitative assessment of gliomas by proton magnetic resonance spectroscopy. Anticanc Res 27:3757–3763
Zeng QS, Li CF, Liu H et al (2007) Distinction between recurrent glioma and radiation injury using magnetic resonance spectroscopy in combination with diffusion-weigthed imaging. Int J Radiat Oncol Biol Phys 68:151–158
Fan GG, Deng QL, WU ZH et al (2006) Usefulness of diffusion/perfusion-weighted MRI in patients with non-enhancing supratentorial brain gliomas: a valuable tool to predict tumor grading? Br J Radiol 79:652–658
Di Costanzo A, Scarabino T, Trojsi F et al (2006) Multiparametric 3T MR approach to the assessment of cerebral gliomas: tumor extent and malignancy. Neuroradiology 48:622–631
Di Costanzo A, Trojsi F, Giannatempo GM et al (2006) Spectroscopic, diffusion and perfusion magnetic resonance imaging at 3.0 Tesla in the delineation of glioblastomas: preliminary results. J Exp Clin Cancer Res 25:383–390
Lemort M, Canizares-Perez AC, Van der Stappen A et al (2007) Progress in magnetic resonance imaging of the brain. Curr Opin Oncol 19:616–622
Jenkinson MD, Du Plessis DG, Waljer C et al (2007) Advanced MRI in the management of adult gliomas. Br J Neurosurg 21:550–561
Al-Okaili RN, Krejza J, Wang S et al (2006) Advanced MR imaging in the diagnosis of intraaxial brain tumors in adults. Radiographics 26:5173–5189
Scarabino T, Popolizio T, Giannatempo GM et al (2007) 3.0 T brain imaging: a five-year experience with morphological and angiographic imaging. Radiol Med 112:82–96
Scarabino T, Giannatempo GM, Popolizio T et al (2007) 3.0 T functional brain imaging: a five-year experience. Radiol Med 112:97–112
Di Costanzo A, Trojsi F, Tosetti M et al (2007) Proton MR spectroscopy of the brain at 3 T: an up date, Eur Radiol 17:1651–1662
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Scarabino, T., Popolizio, T., Trojsi, F. et al. Role of advanced MR imaging modalities in diagnosing cerebral gliomas. Radiol med 114, 448–460 (2009). https://doi.org/10.1007/s11547-008-0351-9
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11547-008-0351-9
Keywords
- Glioma
- Magnetic resonance imaging
- Proton magnetic resonance spectroscopic imaging
- Diffusion magnetic resonance imaging
- Perfusion magnetic resonance imaging